期刊
FEMS YEAST RESEARCH
卷 11, 期 7, 页码 575-586出版社
WILEY-BLACKWELL
DOI: 10.1111/j.1567-1364.2011.00749.x
关键词
Kunitz-type inhibitor; Stichodactyla helianthus; Pichia pastoris; proteases; recombinant miniproinsulin; heterologous protein
资金
- International Foundation for Science (IFS), Sweden [F/4086-1, F/2923-1, F/2923-2, F/2923-3R, F/3342-1, F/3342-2]
- Ibero-American Programme, Spain [CYTED 210RT0398]
- Monasterio (University of Chile
Pichia pastoris is a highly successful system for the large-scale expression of heterologous proteins, with the added capability of performing most eukaryotic post-translational modifications. However, this system has one significant disadvantage - frequent proteolytic degradation by P. pastoris proteases of heterologously expressed proteins. Several methods have been proposed to address this problem, but none has proven fully effective. We tested the effectiveness of a broad specificity protease inhibitor to control proteolysis. A recombinant variant of the BPTI-Kunitz protease inhibitor ShPI-1 isolated from the sea anemone Stichodactyla helianthus, was expressed in P. pastoris. The recombinant inhibitor (rShPI-1A), containing four additional amino acids (EAEA) at the N-terminus, was folded similarly to the natural inhibitor, as assessed by circular dichroism. rShPI-1A had broad protease specificity, inhibiting serine, aspartic, and cysteine proteases similarly to the natural inhibitor. rShPI-1A protected a model protein, recombinant human miniproinsulin (rhMPI), from proteolytic degradation during expression in P. pastoris. The addition of purified rShPI-1A at the beginning of the induction phase significantly protected rhMPI from proteolysis in culture broth. The results suggest that a broad specificity protease inhibitor such as rShPI-1A can be used to improve the yield of recombinant proteins secreted from P. pastoris.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据